LUPIN - Lupin Limited

Lupin Limited Share Market Related News
-: Stock News :- LUPIN 08-06-2022 To 08-06-2022
-: Stock News :- LUPIN 08-06-2022 To 08-06-2022

✔️ Lupin receives tentative approval from USFDA to market Ivacaftor tablets
✔️ Lupin gets USFDA nod for generic drug
✔️ Lupin bags tentative approval from US FDA for Ivacaftor Tablets

View Full Story
-: Stock News :- LUPIN 03-06-2022 To 08-06-2022
-: Stock News :- LUPIN 03-06-2022 To 08-06-2022

✔️ Indian pharma firms hiring former USFDA officers to tide over compliance issues
✔️ Lupin gets USFDA nod for generic drug
✔️ Lupin bags tentative approval from US FDA for Ivacaftor Tablets

View Full Story
-: Stock News :- LUPIN 21-05-2022 To 21-05-2022
-: Stock News :- LUPIN 21-05-2022 To 21-05-2022

✔️ Hold Lupin; target of Rs 610: ICICI Direct
✔️ Buy Lupin: target of Rs 780: Sharekhan
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 20-05-2022 To 21-05-2022
-: Stock News :- LUPIN 20-05-2022 To 21-05-2022

✔️ Lupin: Pricing erosion intensifies in US
✔️ Buy Lupin: target of Rs 780: Sharekhan
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 19-05-2022 To 21-05-2022
-: Stock News :- LUPIN 19-05-2022 To 21-05-2022

✔️ Lupin slips 9%, hits 2-year low on disappointing March quarter results
✔️ Lupin logs net loss of Rs 512 cr in Q4 on rising costs, impairment expense
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 06-05-2022 To 21-05-2022
-: Stock News :- LUPIN 06-05-2022 To 21-05-2022

✔️ Lupin receives USFDA approval to market generic Pregabalin capsules
✔️ Lupin logs net loss of Rs 512 cr in Q4 on rising costs, impairment expense
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 29-04-2022 To 21-05-2022
-: Stock News :- LUPIN 29-04-2022 To 21-05-2022

✔️ Lupin Diagnostics launches regional reference laboratory in Guwahati
✔️ Lupin logs net loss of Rs 512 cr in Q4 on rising costs, impairment expense
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 27-04-2022 To 21-05-2022
-: Stock News :- LUPIN 27-04-2022 To 21-05-2022

✔️ Lupin inks pact with Yabao to market paediatric formulations in China
✔️ Lupin logs net loss of Rs 512 cr in Q4 on rising costs, impairment expense
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 18-04-2022 To 21-05-2022
-: Stock News :- LUPIN 18-04-2022 To 21-05-2022

✔️ Lupin gets USFDA nod to market generic drug
✔️ Lupin gets tentative US FDA nod for pill used to treat hepatitis B
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 14-04-2022 To 21-05-2022
-: Stock News :- LUPIN 14-04-2022 To 21-05-2022

✔️ Lupin Q4 PAT may dip 49.9% YoY to Rs 230.5 cr: Prabhudas Lilladher
✔️ Lupin gets tentative US FDA nod for pill used to treat hepatitis B
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 07-04-2022 To 21-05-2022
-: Stock News :- LUPIN 07-04-2022 To 21-05-2022

✔️ Lupin launches generic contraceptive drug Merzee capsules in US
✔️ Lupin completes acquisition of portfolio of brands from Anglo-French Drugs Industries
✔️ Neutral Lupin; target of Rs 590: Motilal Oswal

View Full Story
-: Stock News :- LUPIN 05-04-2022 To 05-04-2022
-: Stock News :- LUPIN 05-04-2022 To 05-04-2022

✔️ Lupin inks licensing pact with Alvion to market drugs in Southeast Asia
✔️ Lupin inks licensing pact with Alvion to market drugs in Southeast Asia
✔️ Lupin inks licensing pact with Alvion to market drugs in Southeast Asia

View Full Story
-: Stock News :- LUPIN 31-03-2022 To 05-04-2022
-: Stock News :- LUPIN 31-03-2022 To 05-04-2022

✔️ Lupin's New Jersey facility gets 13 US FDA observations
✔️ Lupin inks licensing pact with Alvion to market drugs in Southeast Asia
✔️ Lupin inks licensing pact with Alvion to market drugs in Southeast Asia

View Full Story
-: Stock News :- LUPIN 24-03-2022 To 05-04-2022
-: Stock News :- LUPIN 24-03-2022 To 05-04-2022

✔️ Lupin gets USFDA nod for generic product
✔️ Lupin inks licensing pact with Alvion to market drugs in Southeast Asia
✔️ Lupin inks licensing pact with Alvion to market drugs in Southeast Asia

View Full Story
-: Stock News :- LUPIN 11-03-2022 To 10-03-2022
-: Stock News :- LUPIN 11-03-2022 To 10-03-2022

✔️ Lupin gets USFDA approval to market anti-epilepsy drug in US market
✔️ Lupin diagnostics opens reference laboratory in Kolkata
✔️ Lupin diagnostics opens its first reference laboratory in Kolkata

View Full Story
-: Stock News :- LUPIN 07-03-2022 To 10-03-2022
-: Stock News :- LUPIN 07-03-2022 To 10-03-2022

✔️ Lupin signs Mary Kom as brand ambassador for its Shakti campaign
✔️ Lupin diagnostics opens reference laboratory in Kolkata
✔️ Lupin diagnostics opens its first reference laboratory in Kolkata

View Full Story
-: Stock News :- LUPIN 03-03-2022 To 10-03-2022
-: Stock News :- LUPIN 03-03-2022 To 10-03-2022

✔️ Lupin gets USFDA nod to market generic product
✔️ Lupin gets FDA nod to market Efinaconazole topical solution in US
✔️ Lupin diagnostics opens its first reference laboratory in Kolkata

View Full Story
-: Stock News :- LUPIN 01-03-2022 To 10-03-2022
-: Stock News :- LUPIN 01-03-2022 To 10-03-2022

✔️ Lupin launches generic medication, to be manufactured in Nagpur, in US
✔️ Lupin gets FDA nod to market Efinaconazole topical solution in US
✔️ Lupin diagnostics opens its first reference laboratory in Kolkata

View Full Story
-: Stock News :- LUPIN 18-02-2022 To 10-03-2022
-: Stock News :- LUPIN 18-02-2022 To 10-03-2022

✔️ Lupin receives USFDA approval for antibiotic Solosec
✔️ Lupin receives USFDA approval for antibiotic Solosec
✔️ Lupin diagnostics opens its first reference laboratory in Kolkata

View Full Story
-: Stock News :- LUPIN 15-02-2022 To 10-03-2022
-: Stock News :- LUPIN 15-02-2022 To 10-03-2022

✔️ Accumulate Lupin; target of Rs 950: Prabhudas Lilladher
✔️ Lupin receives USFDA approval for antibiotic Solosec
✔️ Lupin diagnostics opens its first reference laboratory in Kolkata

View Full Story
-: Stock News :- LUPIN 09-02-2022 To 10-03-2022
-: Stock News :- LUPIN 09-02-2022 To 10-03-2022

✔️ What are Lupin CEO Vinita Gupta's plans for growth in US & China?
✔️ Lupin Consolidated December 2021 Net Sales at Rs 4,160.93 crore, up 3.57% Y-o-Y
✔️ Lupin diagnostics opens its first reference laboratory in Kolkata

View Full Story
-: Stock News :- LUPIN 07-02-2022 To 07-02-2022
-: Stock News :- LUPIN 07-02-2022 To 07-02-2022

✔️ Hold Lupin: target of Rs 960: ICICI Direct
✔️ Lupin stock at 52-week low on margin pressure, earnings downgrade
✔️ We are working on developing a China pipeline: Lupin CEO Vinita Gupta

View Full Story
-: Stock News :- LUPIN 04-02-2022 To 04-02-2022
-: Stock News :- LUPIN 04-02-2022 To 04-02-2022

✔️ Lupin consolidated net profit up 24% at Rs 545 crore in Dec quarter
✔️ Lupin Consolidated December 2021 Net Sales at Rs 4,160.93 crore, up 3.57% Y-o-Y
✔️ Lupin slips 5%, nears 52-week low post December quarter results

View Full Story
-: Stock News :- LUPIN 01-02-2022 To 04-02-2022
-: Stock News :- LUPIN 01-02-2022 To 04-02-2022

✔️ Lupin inks licensing pact with Axantia for Pegfilgrastim
✔️ Lupin Consolidated December 2021 Net Sales at Rs 4,160.93 crore, up 3.57% Y-o-Y
✔️ Lupin slips 5%, nears 52-week low post December quarter results

View Full Story
-: Stock News :- LUPIN 19-01-2022 To 04-02-2022
-: Stock News :- LUPIN 19-01-2022 To 04-02-2022

✔️ Lupin inks pact with Shenzhen Foncoo to introduce products in China
✔️ Lupin's acquisition of branded portfolio to boost domestic sales
✔️ Lupin slips 5%, nears 52-week low post December quarter results

View Full Story
-: Stock News :- LUPIN 07-01-2022 To 07-01-2022
-: Stock News :- LUPIN 07-01-2022 To 07-01-2022

✔️ Lupin launches Molnulup for treatment of Covid-19
✔️ Lupin launches Molnulup for COVID-19 treatment
✔️ Lupin launches COVID-19 drug Molnupiravir in India

View Full Story
-: Stock News :- LUPIN 27-12-2021 To 07-01-2022
-: Stock News :- LUPIN 27-12-2021 To 07-01-2022

✔️ Lupin rises 2% on USFDA nod for sevelamer carbonate used in treatment of chronic kidney disease
✔️ Lupin launches Molnulup for COVID-19 treatment
✔️ Lupin launches COVID-19 drug Molnupiravir in India

View Full Story
-: Stock News :- LUPIN 24-12-2021 To 07-01-2022
-: Stock News :- LUPIN 24-12-2021 To 07-01-2022

✔️ Lupin receives tentative USFDA nod for generic Azilsartan Medoxomil tablets
✔️ Lupin receives tentative USFDA nod for generic Azilsartan Medoxomil tablets
✔️ Lupin launches COVID-19 drug Molnupiravir in India

View Full Story
-: Stock News :- LUPIN 21-12-2021 To 07-01-2022
-: Stock News :- LUPIN 21-12-2021 To 07-01-2022

✔️ Buy Lupin: target of Rs 1210: Sharekhan
✔️ Lupin receives tentative USFDA nod for generic Azilsartan Medoxomil tablets
✔️ Lupin launches COVID-19 drug Molnupiravir in India

View Full Story
-: Stock News :- LUPIN 20-12-2021 To 07-01-2022
-: Stock News :- LUPIN 20-12-2021 To 07-01-2022

✔️ Hold Lupin; target of Rs 1015: ICICI Direct
✔️ Lupin receives tentative USFDA nod for generic Azilsartan Medoxomil tablets
✔️ Lupin launches COVID-19 drug Molnupiravir in India

View Full Story
-: Stock News :- LUPIN 17-12-2021 To 16-12-2021
-: Stock News :- LUPIN 17-12-2021 To 16-12-2021

✔️ Neutral Lupin; target of Rs 990: Motilal Oswal
✔️ Lupin gets respite as USFDA clears a plant
✔️ US business rebound key to further upsides in Lupin, VAI may offer relief

View Full Story
-: Stock News :- LUPIN 14-12-2021 To 14-12-2021
-: Stock News :- LUPIN 14-12-2021 To 14-12-2021

✔️ US FDA clears Lupin's Goa plant, paves way for new product approvals
✔️ Lupin receives inspection report from USFDA for Goa manufacturing facility
✔️ Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility
✔️ Lupin shares jump over 7 per cent
✔️ Lupin share price jumps 10% as Goa plant receives EIR from USFDA
✔️ Lupin shares jump 10% in a sudden move; here's why

View Full Story
-: Stock News :- LUPIN 13-12-2021 To 14-12-2021
-: Stock News :- LUPIN 13-12-2021 To 14-12-2021

✔️ Lupin's foray into diagnostics appears a calculated risk
✔️ Lupin receives inspection report from USFDA for Goa manufacturing facility
✔️ Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility
✔️ Lupin shares jump over 7 per cent
✔️ Lupin share price jumps 10% as Goa plant receives EIR from USFDA
✔️ Lupin shares jump 10% in a sudden move; here's why

View Full Story
-: Stock News :- LUPIN 12-12-2021 To 14-12-2021
-: Stock News :- LUPIN 12-12-2021 To 14-12-2021

✔️ Lupin recalls 4,113 cartons of oral contraceptive medicine in US market
✔️ Lupin receives inspection report from USFDA for Goa manufacturing facility
✔️ Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility
✔️ Lupin shares jump over 7 per cent
✔️ Lupin share price jumps 10% as Goa plant receives EIR from USFDA
✔️ Lupin shares jump 10% in a sudden move; here's why

View Full Story
-: Stock News :- LUPIN 10-12-2021 To 14-12-2021
-: Stock News :- LUPIN 10-12-2021 To 14-12-2021

✔️ Lupin to set up 100 diagnostic labs and 1,000 collection centres in 5 yrs
✔️ Lupin announces launch of diagnostics business in India
✔️ Pharma major Lupin announces launch of its diagnostics business
✔️ Lupin forays into diagnostics segment
✔️ Lupin share price jumps 10% as Goa plant receives EIR from USFDA
✔️ Lupin shares jump 10% in a sudden move; here's why

View Full Story
-: Stock News :- LUPIN 30-11-2021 To 14-12-2021
-: Stock News :- LUPIN 30-11-2021 To 14-12-2021

✔️ Lupin launches educational website Sciflix for medical students
✔️ Lupin announces launch of educational mobile website Sciflix
✔️ Pharma major Lupin announces launch of its diagnostics business
✔️ Lupin forays into diagnostics segment
✔️ Lupin share price jumps 10% as Goa plant receives EIR from USFDA
✔️ Lupin shares jump 10% in a sudden move; here's why

View Full Story
-: Stock News :- LUPIN 03-11-2021 To 14-12-2021
-: Stock News :- LUPIN 03-11-2021 To 14-12-2021

✔️ Drug firm Lupin launches generic Fenofibrate capsules in United States
✔️ Lupin launches authorized generic version of Antara in US
✔️ Pharma major Lupin announces launch of its diagnostics business
✔️ Lupin forays into diagnostics segment
✔️ Lupin share price jumps 10% as Goa plant receives EIR from USFDA
✔️ Lupin shares jump 10% in a sudden move; here's why

View Full Story
-: Stock News :- LUPIN 29-10-2021 To 28-10-2021
-: Stock News :- LUPIN 29-10-2021 To 28-10-2021

✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Lupin Standalone September 2021 Net Sales at Rs 2,870.17 crore, down 5.67% Y-o-Y
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 22-10-2021 To 28-10-2021
-: Stock News :- LUPIN 22-10-2021 To 28-10-2021

✔️ Lupin ropes in Hrithik Roshan for ayurvedic energy supplement brand
✔️ Lupin Standalone September 2021 Net Sales at Rs 2,870.17 crore, down 5.67% Y-o-Y
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 14-10-2021 To 28-10-2021
-: Stock News :- LUPIN 14-10-2021 To 28-10-2021

✔️ Lupin recalls 2 hypertension drugs in US due to potential impurity
✔️ Lupin recalls all Irbesartan tablet batches in US due to impurity
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 06-10-2021 To 28-10-2021
-: Stock News :- LUPIN 06-10-2021 To 28-10-2021

✔️ Lupin Q2 PAT seen up 33.1% YoY to Rs 280.9 cr: Prabhudas Lilladher
✔️ Lupin recalls all Irbesartan tablet batches in US due to impurity
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 01-10-2021 To 28-10-2021
-: Stock News :- LUPIN 01-10-2021 To 28-10-2021

✔️ Stock picks by Osho Krishan of Anand Rathi: Buy Lupin, Gujarat Gas
✔️ Lupin recalls all Irbesartan tablet batches in US due to impurity
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 28-09-2021 To 28-10-2021
-: Stock News :- LUPIN 28-09-2021 To 28-10-2021

✔️ Lupin forays into diagnostics business; launch expected next month
✔️ Lupin recalls all Irbesartan tablet batches in US due to impurity
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 23-09-2021 To 28-10-2021
-: Stock News :- LUPIN 23-09-2021 To 28-10-2021

✔️ Lupin's Goa plant: USFDA finds certain investigation, material testing deficiencies
✔️ Lupin recalls all Irbesartan tablet batches in US due to impurity
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 20-09-2021 To 28-10-2021
-: Stock News :- LUPIN 20-09-2021 To 28-10-2021

✔️ Lupin slips 4% as Goa plant gets 7 observations from the USFDA
✔️ Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 15-09-2021 To 28-10-2021
-: Stock News :- LUPIN 15-09-2021 To 28-10-2021

✔️ Lupin launches generic Duexis tablets in US to treat rheumatoid arthritis
✔️ Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 06-09-2021 To 28-10-2021
-: Stock News :- LUPIN 06-09-2021 To 28-10-2021

✔️ TB Alliance ropes in Lupin to bolster global supplies of Pretomanid
✔️ Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 29-08-2021 To 28-10-2021
-: Stock News :- LUPIN 29-08-2021 To 28-10-2021

✔️ Pharmaceutical firms turn focus to inhalation products for Covid-19
✔️ Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 23-08-2021 To 28-10-2021
-: Stock News :- LUPIN 23-08-2021 To 28-10-2021

✔️ Buy Lupin; target of Rs 1400: Sharekhan
✔️ Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 19-08-2021 To 28-10-2021
-: Stock News :- LUPIN 19-08-2021 To 28-10-2021

✔️ Neutral Lupin; target of Rs 1040: Motilal Oswal
✔️ Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed
✔️ Buy Lupin; target of Rs 1,210: Sharekhan
✔️ Lupin: Competitive pressure remains in the US market
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 17-08-2021 To 28-10-2021
-: Stock News :- LUPIN 17-08-2021 To 28-10-2021

✔️ Hold Lupin: target of Rs 1025: ICICI Direct
✔️ Lupin Receives Tentative Nod For Anti-Seizure Drug; Stock Edges Higher
✔️ Lupin bets big on inhalation segment, plans to enter Chinese market
✔️ Lupin gets tentative nod from USFDA to market partial-onset seizures drug
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 13-08-2021 To 28-10-2021
-: Stock News :- LUPIN 13-08-2021 To 28-10-2021

✔️ Lupin: Margin guidance downgrade keeps us cautious
✔️ Lupin Receives Tentative Nod For Anti-Seizure Drug; Stock Edges Higher
✔️ Lupin bets big on inhalation segment, plans to enter Chinese market
✔️ Lupin gets tentative nod from USFDA to market partial-onset seizures drug
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 11-08-2021 To 28-10-2021
-: Stock News :- LUPIN 11-08-2021 To 28-10-2021

✔️ Lupin's Q1 disappoints Street as sales hit a bump in the US
✔️ Lupin falls 7% post Q1 results, hits over three month low
✔️ Lupin bets big on inhalation segment, plans to enter Chinese market
✔️ Lupin gets tentative nod from USFDA to market partial-onset seizures drug
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 30-07-2021 To 28-10-2021
-: Stock News :- LUPIN 30-07-2021 To 28-10-2021

✔️ Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business
✔️ Lupin falls 7% post Q1 results, hits over three month low
✔️ Lupin bets big on inhalation segment, plans to enter Chinese market
✔️ Lupin gets tentative nod from USFDA to market partial-onset seizures drug
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 13-07-2021 To 28-10-2021
-: Stock News :- LUPIN 13-07-2021 To 28-10-2021

✔️ Lupin Q1 PAT seen up 258.7% YoY to Rs 389.9 cr: KRChoksey
✔️ Lupin launches generic antifungal product in US market
✔️ Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis
✔️ Lupin gets tentative nod from USFDA to market partial-onset seizures drug
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 02-07-2021 To 28-10-2021
-: Stock News :- LUPIN 02-07-2021 To 28-10-2021

✔️ Lupin Gains Nearly 1% As Subsidiary Gets New Drug Approval
✔️ Lupin launches generic antifungal product in US market
✔️ Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis
✔️ Lupin gets tentative nod from USFDA to market partial-onset seizures drug
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 30-06-2021 To 28-10-2021
-: Stock News :- LUPIN 30-06-2021 To 28-10-2021

✔️ USFDA warning letter on Lupin's Somerset facility cites repeated GMP violations at Lupin's manufacturing network
✔️ Lupin launches generic antifungal product in US market
✔️ Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis
✔️ Lupin gets tentative nod from USFDA to market partial-onset seizures drug
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 17-06-2021 To 28-10-2021
-: Stock News :- LUPIN 17-06-2021 To 28-10-2021

✔️ Lupin gets USFDA nod for Sevelamer tablets used for treatment of kidney disease
✔️ Lupin launches generic antifungal product in US market
✔️ Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis
✔️ Lupin gets tentative nod from USFDA to market partial-onset seizures drug
✔️ Settling regulatory hurdles in the US crucial for Lupin
✔️ Lupin Consolidated September 2021 Net Sales at Rs 4,091.33 crore, up 6.68% Y-o-Y
✔️ Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2
✔️ Lupin reports consolidated net loss of Rs 2,098 crore in Q2

View Full Story
-: Stock News :- LUPIN 14-06-2021 To 13-06-2021
-: Stock News :- LUPIN 14-06-2021 To 13-06-2021

✔️ Lupin gets UK nod to launch generic asthma inhaler drug Fostair
✔️ USFDA warning letter to Lupin's US facility
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 12-06-2021 To 13-06-2021
-: Stock News :- LUPIN 12-06-2021 To 13-06-2021

✔️ Review | 'Lupin 2': Omar Sy's gentleman thief is everything you wanted him to be
✔️ USFDA warning letter to Lupin's US facility
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 07-06-2021 To 13-06-2021
-: Stock News :- LUPIN 07-06-2021 To 13-06-2021

✔️ Lupin launches digital asthma educator platform
✔️ Lupin launches digital asthma educator platform
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 04-06-2021 To 13-06-2021
-: Stock News :- LUPIN 04-06-2021 To 13-06-2021

✔️ Lupin launches generic inhalation product in US market
✔️ Lupin launches generic inhalation product in US market
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 03-06-2021 To 13-06-2021
-: Stock News :- LUPIN 03-06-2021 To 13-06-2021

✔️ Lupin to enter digital healthcare space in India
✔️ Lupin to enter digital healthcare space; to provide platform for doctors
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 29-05-2021 To 13-06-2021
-: Stock News :- LUPIN 29-05-2021 To 13-06-2021

✔️ 5 binge-worthy Netflix series coming in June
✔️ Lupin to enter digital healthcare space; to provide platform for doctors
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 27-05-2021 To 13-06-2021
-: Stock News :- LUPIN 27-05-2021 To 13-06-2021

✔️ Lupin gets $50 million from Boehringer Ingelheim as 'milestone payment' for anti-cancer drug
✔️ Lupin to enter digital healthcare space; to provide platform for doctors
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 16-05-2021 To 13-06-2021
-: Stock News :- LUPIN 16-05-2021 To 13-06-2021

✔️ Lupin eyes deals with foreign players for covid drugs, jabs
✔️ Lupin to enter digital healthcare space; to provide platform for doctors
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 15-05-2021 To 13-06-2021
-: Stock News :- LUPIN 15-05-2021 To 13-06-2021

✔️ Why short strangle may be the ideal strategy for Lupin this week
✔️ Brokerages raise target price on Lupin by up to 50%
✔️ Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
✔️ Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
✔️ Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit
✔️ Lupin gets warning letter from US health regulator for its Somerset facility
✔️ Lupin gets warning letter from US health regulator for Somerset facility
✔️ Lupin gets USFDA's warning letter for its Somerset facility in US

View Full Story
-: Stock News :- LUPIN 14-05-2021 To 13-05-2021
-: Stock News :- LUPIN 14-05-2021 To 13-05-2021

✔️ What should investors do with Lupin post Q2 result: buy, sell or hold?
✔️ Margin improvement offsets weak sales for Lupin in March quarter
✔️ Keen to bring in mRNA products: Lupin MD
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 12-04-2021 To 13-05-2021
-: Stock News :- LUPIN 12-04-2021 To 13-05-2021

✔️ LUPIN Q4 PAT seen up 3.5% YoY to Rs. 317.2 cr: Sharekhan
✔️ Margin improvement offsets weak sales for Lupin in March quarter
✔️ Keen to bring in mRNA products: Lupin MD
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 11-03-2021 To 13-05-2021
-: Stock News :- LUPIN 11-03-2021 To 13-05-2021

✔️ Lupin on firm ground with US product launches, but high base in Q4 a challenge
✔️ Margin improvement offsets weak sales for Lupin in March quarter
✔️ Keen to bring in mRNA products: Lupin MD
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 02-03-2021 To 13-05-2021
-: Stock News :- LUPIN 02-03-2021 To 13-05-2021

✔️ Lupin launches Penicillamine tablets for treating Wilson's disease in US markets
✔️ Margin improvement offsets weak sales for Lupin in March quarter
✔️ Keen to bring in mRNA products: Lupin MD
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 17-02-2021 To 13-05-2021
-: Stock News :- LUPIN 17-02-2021 To 13-05-2021

✔️ Lupin launches Posaconazole delayed-release tablets; share dips 2%
✔️ Margin improvement offsets weak sales for Lupin in March quarter
✔️ Keen to bring in mRNA products: Lupin MD
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 08-02-2021 To 13-05-2021
-: Stock News :- LUPIN 08-02-2021 To 13-05-2021

✔️ Buy Lupin; target of Rs 1350: Sharekhan
✔️ Margin improvement offsets weak sales for Lupin in March quarter
✔️ Keen to bring in mRNA products: Lupin MD
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 05-02-2021 To 13-05-2021
-: Stock News :- LUPIN 05-02-2021 To 13-05-2021

✔️ Buy Lupin; target of Rs 1287: Prabhudas Lilladher
✔️ Buy Lupin; target of Rs 1165: ICICI Direct
✔️ Keen to bring in mRNA products: Lupin MD
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 03-02-2021 To 13-05-2021
-: Stock News :- LUPIN 03-02-2021 To 13-05-2021

✔️ Buy Lupin; target of Rs 1180: Motilal Oswal
✔️ Lupin: New launches and market share gains are likely to override pricing erosion
✔️ Keen to bring in mRNA products: Lupin MD
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 01-02-2021 To 13-05-2021
-: Stock News :- LUPIN 01-02-2021 To 13-05-2021

✔️ Buy Lupin; target of Rs 1350: Sharekhan
✔️ Lupin to enter Chinese market in next one year
✔️ Lupin plans expansion, aims to enter Chinese market in the next one year
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 29-01-2021 To 13-05-2021
-: Stock News :- LUPIN 29-01-2021 To 13-05-2021

✔️ Regulatory clearances, US growth near term triggers for Lupin
✔️ Lupin posts net profit of 438.25 cr in December quarter
✔️ Lupin reports Rs 438.3 crore net profit in Q3 FY21, led by improved sales in US, India
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 25-01-2021 To 13-05-2021
-: Stock News :- LUPIN 25-01-2021 To 13-05-2021

✔️ Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets
✔️ Lupin share price gains 2% on USFDA approval
✔️ Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 18-01-2021 To 13-05-2021
-: Stock News :- LUPIN 18-01-2021 To 13-05-2021

✔️ New product launches to drive growth for Lupin, US business a key trigger
✔️ Lupin share price gains 2% on USFDA approval
✔️ Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 09-01-2021 To 13-05-2021
-: Stock News :- LUPIN 09-01-2021 To 13-05-2021

✔️ Lupin review: Netflix starts the year with a fabulous new show about a gentleman thief
✔️ Lupin share price gains 2% on USFDA approval
✔️ Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 07-01-2021 To 13-05-2021
-: Stock News :- LUPIN 07-01-2021 To 13-05-2021

✔️ Lupin gets USFDA nod for generic diabetes drug
✔️ Lupin gets USFDA nod for generic diabetes drug
✔️ Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 29-12-2020 To 13-05-2021
-: Stock News :- LUPIN 29-12-2020 To 13-05-2021

✔️ Lupin launches Mycophenolate Mofetil tablets in US
✔️ Lupin gets USFDA nod for generic diabetes drug
✔️ Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 22-12-2020 To 13-05-2021
-: Stock News :- LUPIN 22-12-2020 To 13-05-2021

✔️ Lupin shares rise 3% on USFDA nod
✔️ Lupin gets USFDA nod for generic diabetes drug
✔️ Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 18-12-2020 To 13-05-2021
-: Stock News :- LUPIN 18-12-2020 To 13-05-2021

✔️ Lupin gets USFDA nod for marketing cholesterol drug
✔️ Lupin gets USFDA nod for generic diabetes drug
✔️ Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 01-12-2020 To 13-05-2021
-: Stock News :- LUPIN 01-12-2020 To 13-05-2021

✔️ Lupin gets USFDA nod to market generic Penicillamine tablets
✔️ Lupin gets USFDA nod for generic diabetes drug
✔️ Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 25-11-2020 To 13-05-2021
-: Stock News :- LUPIN 25-11-2020 To 13-05-2021

✔️ Lupin launches generic immunosuppressant drug in US
✔️ Lupin gets USFDA nod for generic diabetes drug
✔️ Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 12-11-2020 To 13-05-2021
-: Stock News :- LUPIN 12-11-2020 To 13-05-2021

✔️ Lupin, Concord Biotech get USFDA nod for immunosuppressant capsules
✔️ Buy Lupin; target of Rs 1212: Prabhudas Lilladher
✔️ Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 09-11-2020 To 13-05-2021
-: Stock News :- LUPIN 09-11-2020 To 13-05-2021

✔️ Buy Lupin; target of Rs 1120: HDFC Securities
✔️ USFDA issues 13 observations after inspection of Lupin arm's facility in US
✔️ USFDA issues 13 observations after inspection of Lupin arm's Somerset facility
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 07-11-2020 To 13-05-2021
-: Stock News :- LUPIN 07-11-2020 To 13-05-2021

✔️ Hold Lupin; target of Rs 985: ICICI Direct
✔️ Lupin hit by cyberattack; threat increases for pharma firms amid COVID-19
✔️ USFDA issues 13 observations after inspection of Lupin arm's Somerset facility
✔️ Lupin aims to bring COVID-19 drugs, jabs; approaches Gilead for Remdesivir
✔️ Lupin willing to take partners to bring mRNA Covid-19 vaccines to India
✔️ Lupin back in the black in FY20, reports Rs 1,216-crore profit
✔️ Lupin Q4 net rises 18% at 460 cr
✔️ Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr
✔️ Lupin Q4 Net profit grows 18.2% led by cost optimisation, India sales growth

View Full Story
-: Stock News :- LUPIN 06-11-2020 To 04-11-2020
-: Stock News :- LUPIN 06-11-2020 To 04-11-2020

✔️ Lupin: Covid opportunity strengthens US business
✔️ Lupin expects 18.5% EBITDA margins in the second half of FY21 led by rebound of US, India businesses
✔️ Lupin experiences information security incident, select IT systems affected
✔️ Lupin confirms 'security incident', days after Dr Reddy's cyber attack
✔️ Lupin shares fall 2% in strong market post September quarter results
✔️ Lupin Q2 net profit at Rs 211 crore
✔️ With US sales recovering, Lupin Q2 profit up 97% over Q1 to Rs 211 cr
✔️ Lupin reports Rs 211 crore net profit in Q2FY21, led by recovery in US business
✔️ Lupin Q2 Preview: Adjusted profit may decline sharply on subdued revenue, operating performance

View Full Story
-: Stock News :- LUPIN 05-11-2020 To 04-11-2020
-: Stock News :- LUPIN 05-11-2020 To 04-11-2020

✔️ Lupin: Q2 unimpressive, more triggers required to drive stock
✔️ Lupin expects 18.5% EBITDA margins in the second half of FY21 led by rebound of US, India businesses
✔️ Lupin experiences information security incident, select IT systems affected
✔️ Lupin confirms 'security incident', days after Dr Reddy's cyber attack
✔️ Lupin shares fall 2% in strong market post September quarter results
✔️ Lupin Q2 net profit at Rs 211 crore
✔️ With US sales recovering, Lupin Q2 profit up 97% over Q1 to Rs 211 cr
✔️ Lupin reports Rs 211 crore net profit in Q2FY21, led by recovery in US business
✔️ Lupin Q2 Preview: Adjusted profit may decline sharply on subdued revenue, operating performance

View Full Story
-: Stock News :- LUPIN 14-10-2020 To 04-11-2020
-: Stock News :- LUPIN 14-10-2020 To 04-11-2020

✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani for short term
✔️ Lupin expects 18.5% EBITDA margins in the second half of FY21 led by rebound of US, India businesses
✔️ Lupin experiences information security incident, select IT systems affected
✔️ Lupin confirms 'security incident', days after Dr Reddy's cyber attack
✔️ Lupin shares fall 2% in strong market post September quarter results
✔️ Lupin Q2 net profit at Rs 211 crore
✔️ With US sales recovering, Lupin Q2 profit up 97% over Q1 to Rs 211 cr
✔️ Lupin reports Rs 211 crore net profit in Q2FY21, led by recovery in US business
✔️ Lupin Q2 Preview: Adjusted profit may decline sharply on subdued revenue, operating performance

View Full Story
-: Stock News :- LUPIN 18-08-2022 To 18-08-2022
-: Stock News :- LUPIN 18-08-2022 To 18-08-2022

✔️ Lupin receives USFDA nod for rufinamide tablets to treat seizures
✔️ Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures

View Full Story
-: Stock News :- LUPIN 14-08-2022 To 18-08-2022
-: Stock News :- LUPIN 14-08-2022 To 18-08-2022

✔️ Lupin revising product portfolio in US to overcome price erosion impact
✔️ Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures

View Full Story
-: Stock News :- LUPIN 12-08-2022 To 18-08-2022
-: Stock News :- LUPIN 12-08-2022 To 18-08-2022

✔️ F&O Strategy: Nandish Shah recommends a Bull Spread on Lupin
✔️ Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures

View Full Story
-: Stock News :- LUPIN 04-08-2022 To 04-08-2022
-: Stock News :- LUPIN 04-08-2022 To 04-08-2022

✔️ Lupin reports Q1 net loss at Rs 89 cr on lower US sales; revenue falls 12%
✔️ Pharma major Lupin's sales in India and US decline in Q1

View Full Story
-: Stock News :- LUPIN 25-07-2022 To 04-08-2022
-: Stock News :- LUPIN 25-07-2022 To 04-08-2022

✔️ Lupin gets USFDA approval for generic blood pressure lowering drug
✔️ Pharma major Lupin's sales in India and US decline in Q1

View Full Story
-: Stock News :- LUPIN 07-07-2022 To 04-08-2022
-: Stock News :- LUPIN 07-07-2022 To 04-08-2022

✔️ Lupin's Somerset manufacturing plant receives EIR from US FDA
✔️ Pharma major Lupin's sales in India and US decline in Q1

View Full Story

No More Records...